| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/27/2013 | CN102234313B Method for synthesizing pidotimod |
| 02/26/2013 | US8383919 Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof |
| 02/26/2013 | US8383772 Ang-(1-7) receptor agonist |
| 02/26/2013 | US8383768 CD133 epitopes |
| 02/26/2013 | US8383767 Immunogenic protein carrier containing an antigen presenting cell binding domain and a cysteine-rich domain |
| 02/26/2013 | US8383337 Methods using metal oxide particles for analyte detection |
| 02/26/2013 | US8383125 Antimicrobial protein |
| 02/21/2013 | WO2013025861A1 Compounds and methods for augmenting permeability barriers |
| 02/21/2013 | WO2013024720A1 PEPTIDE CATALYST AND ALDEHYDE ASYMMETRIC α－AMINATION USING SAME |
| 02/21/2013 | WO2013024035A1 Folate conjugates of albumin-binding entities |
| 02/21/2013 | US20130046077 Dolastatin 15 derivatives |
| 02/21/2013 | US20130045930 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/21/2013 | US20130045925 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
| 02/21/2013 | CA2839647A1 Folate conjugates of albumin-binding entities |
| 02/20/2013 | EP2559697A1 Novel lipid peptide and hydrogel |
| 02/20/2013 | CN102939300A Preparation of crystalline ezatiostat hydrochloride ansolvate form d |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8377871 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | CA2658525C Smac peptidomimetics useful as iap inhibitors |
| 02/14/2013 | US20130040892 Iap bir domain binding compounds |
| 02/13/2013 | EP2557088A1 Physiologically active peptides |
| 02/13/2013 | CN1953988B Peptides derived from human BPLP protein, polynucleotides coding for the peptides and antibodies directed against the peptides |
| 02/13/2013 | CN102924568A Synthetic peptides, as well as preparation method and application thereof |
| 02/13/2013 | CN102924567A Peptide compound and preparation method and use of peptide compound |
| 02/13/2013 | CN102924532A Fe-hydrogenase model compound, its preparation method, photo-catalytic hydrogen production system containing it, and hydrogen preparation method of system |
| 02/13/2013 | CN101810847B Inflammation-inhibiting compounds |
| 02/12/2013 | US8372959 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 02/12/2013 | US8372949 Molecular recognition of materials |
| 02/12/2013 | US8372948 12 human secreted proteins |
| 02/12/2013 | CA2493471C Compounds binding to p-selectin |
| 02/07/2013 | WO2013017026A1 Hcv protease inhibitors |
| 02/07/2013 | US20130035478 Pyrrolysine analogs |
| 02/07/2013 | US20130035470 Crystalline oxidized glutathione and production method therefor |
| 02/07/2013 | US20130035297 Compounds for enzyme inhibition |
| 02/07/2013 | US20130035292 NMDA Receptors Modulators and Uses Thereof |
| 02/07/2013 | US20130034519 Organic compounds and their uses |
| 02/06/2013 | EP2552940A2 Peptides for promoting angiogenesis and an use thereof |
| 02/06/2013 | EP2552938A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| 02/06/2013 | EP2552470A2 Peptides for promoting angiogenesis and an use thereof |
| 02/06/2013 | CN102917726A Interferon analogs |
| 02/06/2013 | CN102917694A Tablet formulation of ezatiostat |
| 02/06/2013 | CN102911256A Radioactive label polypeptide coordination complex and preparation method and application thereof |
| 02/06/2013 | CN102911255A Preparation method of 18F marker containing 1,4-disubstituted triazole structure |
| 02/06/2013 | CN102911254A HCV (hepatitis C virus) protease inhibitor |
| 02/06/2013 | CN102911253A New dipeptide derivative and salt for detecting enzyme activity |
| 02/06/2013 | CN102911252A Cationic lipid containing peptide dendrimer, transgenic carrier and preparation method and application of transgenic carrier |
| 02/06/2013 | CN102911251A Bicyclol-glutathione conjugate and preparation method and application thereof |
| 02/06/2013 | CN102160890B Pharmaceutical composition comprising an analgesic peptide |
| 02/05/2013 | US8367801 Proteinaceous compounds |
| 02/05/2013 | US8367799 TEM8 peptides and vaccines comprising the same |
| 02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
| 02/05/2013 | US8367617 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 02/05/2013 | US8367607 Oxyntomodulin peptide analogue |
| 02/05/2013 | CA2515975C Peptide derivatives having .beta.-secretase inhibitory activity |
| 01/31/2013 | WO2013016081A1 Notch pathway signaling inhibitor compound |
| 01/31/2013 | WO2013013273A1 Modulators of protease activated receptors |
| 01/31/2013 | US20130030059 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/31/2013 | US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof |
| 01/31/2013 | CA2841178A1 Notch pathway signaling inhibitor compound |
| 01/30/2013 | EP2549990A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 01/30/2013 | CN102905703A Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases, etc. |
| 01/30/2013 | CN102898507A Thrombolysis oligopeptide-imidazolidine binary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102898504A Antioxidation active synthetic peptide and purpose thereof |
| 01/30/2013 | CN102898503A Antioxidation-activity synthetic peptides and application thereof |
| 01/30/2013 | CN102898502A Coumarin derivative, and its preparation method and application |
| 01/30/2013 | CN102898501A Method for preparing bortezomib with (one)-cypress camphor serving as chiral auxiliary reagent |
| 01/30/2013 | CN101914133B Directional synthesis method for 21(S) argatroban |
| 01/30/2013 | CN101432295B Application of peptide from lactoprotein |
| 01/29/2013 | US8362084 Histone deacetylases, and uses related thereto |
| 01/29/2013 | US8361970 Growth factor binding molecules |
| 01/29/2013 | US8361969 Designer cyclic peptides—HIV gp120 antagonists and their applications |
| 01/29/2013 | US8361748 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester |
| 01/29/2013 | US8361740 Peptide standards |
| 01/29/2013 | US8361479 Promiscuous PAP CD4 T cell epitopes |
| 01/29/2013 | CA2584643C New, topically applicable actives against mimic and age-related wrinkles |
| 01/29/2013 | CA2482995C Low-cost production of peptides |
| 01/24/2013 | WO2013012101A1 Fatty acid tripeptide salt and antibacterial composition containing same |
| 01/24/2013 | US20130023644 Beta-amino acids |
| 01/24/2013 | US20130022573 Macrocyclic inhibitors of flaviviridae viruses |
| 01/23/2013 | EP2548017A2 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/23/2013 | CN102892878A Cell culture medium comprising small peptides |
| 01/23/2013 | CN102892417A Compounds for immunoproteasome inhibition |
| 01/23/2013 | CN101979402B Marine cyclic peptide compound and preparation method and use thereof |
| 01/22/2013 | US8357774 Polypeptide and process for producing the same |
| 01/22/2013 | CA2667031C Hcv ns3 protease inhibitors |
| 01/22/2013 | CA2455638C Peptide-based multimeric targeted contrast agents |
| 01/22/2013 | CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use |
| 01/22/2013 | CA2338524C Inhibitors of urokinase and blood vessel formation |
| 01/22/2013 | CA2325629C Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide |
| 01/17/2013 | WO2013009647A1 Glutathione analogs and uses thereof |
| 01/17/2013 | WO2013008123A1 Enkephalin analogues |
| 01/17/2013 | WO2012161497A3 Peptide derivatives having a superior moisturizing effect and uses thereof |
| 01/17/2013 | CA2840317A1 Enkephalin analogues |
| 01/16/2013 | EP2545041A1 Bioluminescent assays using cyanobenzothiazole compounds |
| 01/16/2013 | CN102875651A Anti-tumor target-activated polypeptide doxorubicin and preparation method and application thereof |
| 01/16/2013 | CN102875643A Major peptide fragment for synthesis of somatostatin |